Updated results from AVENANCE: Real-world effectiveness of avelumab first-line maintenance (1LM) in patients (pts) with advanced urothelial carcinoma (aUC) and analysis of subsequent treatment.

被引：10

作者：

Barthelemy, Philippe ^{[1
]}

Loriot, Yohann ^{[2
]}

Thibault, Constance ^{[3
]}

Gross-Goupil, Marine ^{[4
]}

Eymard, Jean Christophe ^{[5
]}

Voog, Eric ^{[6
]}

Abraham Jaillon, Christine ^{[7
]}

Le Moulec, Sylvestre ^{[8
]}

Chasseray, Matthieu ^{[9
]}

Gobert, Aurelien ^{[10
]}

Auberger, Benjamin ^{[11
]}

Viala, Caroline ^{[12
]}

Cabart, Mathilde ^{[13
]}

Kazan, Eyad ^{[14
]}

Lorgis, Veronique ^{[15
]}

Hilgers, Werner ^{[16
]}

Josse, Constant ^{[17
]}

Lambert, Prisca ^{[18
]}

Solbes, Marie-Noelle ^{[19
]}

Flechon, Aude ^{[20
]}

机构：

[1] Inst Cancerol Strasbourg Europe, Med Oncol, Strasbourg, France

[2] Inst Cancerol Gustave Roussy, Villejuif, France

[3] Univ Paris Cite, Hop Europeen Georges Pompidou, AP HP Ctr, Inst Canc Paris Carpem, Paris, France

[4] Bordeaux Univ Hosp, Bordeaux, France

[5] Inst Cancerol Jean Godinot, Reims, France

[6] Clin Victor Hugo, ILC Grp, Le Mans, France

[7] Foch Hosp, Serv Oncol Med, Suresnes, France

[8] Grp Radiotherapie & Oncol Pyrenees, Clin Marzet, Pau, France

[9] Clin Pasteur, Ctr Finisterien Radiothe & Oncol, Brest, France

[10] St Gregoire Hosp, St Gregoire, France

[11] CHRU Brest, Inst Cancerol & Hematol ICH Hop, Morvan, France

[12] CHU Nantes, Nantes, France

[13] Inst Bergonie, Bordeaux, France

[14] Clin Louviere, Ramsay Hlth Grp, Dept Med Oncol, Lille, France

[15] Inst Cancerol Bourgogne, Dijon, France

[16] Avignon Provence Canc Inst, Avignon, France

[17] Exystat, Malakoff, France

[18] Pfizer Oncol, Paris, France

[19] Merck Sante SAS, Merck KGaA, Lyon, France

[20] Ctr Leon Berard, Lyon, France

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期

关键词：

261-492-3532-2370-7650-2700; 283-183-138-12099; 130-540-543-12277; 261-566-148-11298; 8; 6; 3; 1880; 3590; 4044; 260; 112; 176; 3224; 65; 62; 295; 10; 2; 1;

D O I：

10.1200/JCO.2024.42.4_suppl.561

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：561 / 561

页数：1

共 50 条

[21] Avelumab first-line maintenance (1LM) for advanced urothelial carcinoma (aUC): Long-term patient-reported outcomes (PROs) in the phase 3 JAVELIN Bladder 100 trial
Grivas, Petros
Aragon-Ching, Jeanny B.
Bellmunt, Joaquim
Loriot, Yohann
Sridhar, Srikala S.
Su, Po-Jung
Park, Se Hoon
Yamamoto, Yoshiaki
Jacob, Natalia
Hoffman, Jason
Kearney, Mairead
Schlichting, Michael
Powles, Thomas
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 581 - 581
[22] Real-world data from early access and patient access programs of avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma in Australia
Moujaber, Tania
Tran Ben
Liow, Elizabeth
Clay, Timothy
Bennett, Geer
Kearney, Mairead
Gibberd, Alison
Gurney, Howard
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 94 - 95
[23] Avelumab Maintenance Treatment After First-line Chemotherapy in Advanced Urothelial Carcinoma-A Cost-Effectiveness Analysis
Lin, Dong
Luo, Shaohong
Lin, Shen
Zhong, Lixian
Zhou, Wei
Gu, Dian
Huang, Xiaoting
Chen, Qixin
Xu, Xiongwei
Weng, Xiuhua
CLINICAL GENITOURINARY CANCER, 2022, 21 (01) : 8 - 15
[24] Avelumab first-line maintenance therapy for locally advanced/metastatic urothelial carcinoma: Results from the real-world US PATRIOT-II study.
Grivas, Petros
Barata, Pedro C.
Moon, Helen H.
Gupta, Shilpa
Hutson, Thomas E.
Sternberg, Cora N.
Brown, Jason
Dave, Vaidehi
Downey, Chad
Shillington, Alicia C.
Katzenstein, Howard
Kirker, Melissa
Hanson, Sarah
Liu, Frank X.
Morris, Valerie A.
Bhanegaonkar, Abhijeet
Sonpavde, Guru P.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 697 - 697
[25] Avenue: A prospective observational study of real-world treatment patterns and treatment outcomes in patients with advanced or metastatic urothelial carcinoma treated with avelumab first-line maintenance therapy
Gschwend, J.
Belz, H.
Boegemann, M.
Niegisch, G.
Janssen, J.
Henrici, M.
Schostak, M.
Gruenwald, V
Wille, K.
Wunderlich, H.
Schlack, K.
Stark, L.
Mundel, T.
Grimm, M. O.
ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 266 - 266
[26] Baseline characteristics from a retrospective, observational, US-based, multicenter, real-world (RW) study of avelumab first-line maintenance (1LM) in locally advanced/metastatic urothelial carcinoma (la/mUC) (PATRIOT-II).
Grivas, Petros
Barata, Pedro C.
Moon, Helen
Hutson, Thomas E.
Gupta, Shilpa
Sternberg, Cora N.
Dave, Vaidehi
Downey, Chad
Shillington, Alicia C.
Devgan, Geeta
Kirker, Melissa
Thakkar, Sheena
Katzenstein, Howard M.
Bhanegaonkar, Abhijeet
Liu, Frank
Brown, Jason
Sonpavde, Guru P.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
[27] COST-EFFECTIVENESS OF AVELUMAB AS FIRST-LINE MAINTENANCE TREATMENT FOR LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA IN FINLAND
Karttunen, E.
Jaaskelainen, S.
Hervonen, P.
Chang, J.
Kearney, M.
VALUE IN HEALTH, 2022, 25 (01) : S99 - S99
[28] Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): Long-term outcomes from the JAVELIN Bladder 100 trial in older patients (pts)
Gupta, S.
Climent Duran, M. A.
Sridhar, S.
Powles, T. B.
Bellmunt, J.
Tyroller, K.
Guenther, S.
di Pietro, A.
Grivas, P.
ANNALS OF ONCOLOGY, 2023, 34 : S1207 - S1207
[29] Real-world prescribing patterns for first-line and maintenance treatment of patients with advanced urothelial cancer (UC)
Inderjeeth, Andrisha-Jade
O'haire, Sophie
Gibbs, Peter
Wong, Lih-Ming
Zhang, Alison
Manohar, Paul
James, Lynam
Sengupta, Shomik
Wong, Shirley
Weickhardt, Andrew
Tran, Ben
Conduit, Ciara
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 95 - 95
[30] Maintenance therapy with avelumab as the first-line treatment in patients with metastatic urothelial carcinoma: A real-world, ambispective RAVE-Bladder study.
Gridneva, Yana
Sultanbaev, Alexander, Sr.
Anzhiganova, Yulia
Gluzman, Mark
Mochalova, Anastasia
Shkurat, Alexey
Parsadanova, Elvira
Israelyan, Edgar
Murzina, Yulia
Kalpinsky, Aleksey
Stativko, Olesia
Karabina, Elena
Kfln, Artyom
Petkau, Vladislav
Tovbik, Natalya
Turganova, Maria
Safina, Sufiia
Kopyltsov, Evgeny
Volkova, Maria
Tsimafeyeu, Ilya
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)

← 1 2 3 4 5 →